Financials
- Market Capitalization 334.14 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.47
ratio cours/chiffre d'affaires
11.12 K
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3263 | GALT Galectin Therapeutics Inc. - Common Stock | 4.92 USD | -7.87% | +6.96% | +87.79% | +75.71% | 324.02 M USD | ||
| 3267 | CTNM Contineum Therapeutics, Inc. - Common stock | 14.33 USD | -1.65% | -8.84% | +13.10% | -6.16% | 331.01 M USD | ||
| 3316 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 4.03 USD | -0.49% | +1.00% | +16.47% | +4.40% | 311.07 M USD | ||
| 3318 | FHTX Foghorn Therapeutics Inc. - Common Stock | 5.29 USD | -1.67% | -13.28% | +28.40% | +29.66% | 310.60 M USD |